CTAS vs MEDP · P/E 51, rev $11.26B vs P/E 25, rev $707.3M
Cintas Corporation (CTAS) versus Medpace Holdings Inc (MEDP) — a side-by-side from cached financials, not a winner call.
Cintas Corporation (CTAS) is a specialty business services company listed on US.
Medpace Holdings Inc (MEDP) is a diagnostics & research company listed on US.
Latest reported CTAS revenue for 2026-05-31 was $11.26B. Net income was $2.00B. Revenue was up 8.9% from 2025-05-31 to 2026-05-31. CTAS currently screens at market cap $89.01B and trailing P/E 51.3.
Latest reported MEDP revenue for 2026-06-30 was $707.3M. Net income was $121.4M. Revenue was up 0.1% from 2026-03-31 to 2026-06-30. MEDP currently screens at market cap $9.30B and trailing P/E 24.7.
CTAS currently screens at market cap $89.01B and trailing P/E 51.3. MEDP currently screens at market cap $9.30B and trailing P/E 24.7.
Not investment advice. Open the CTAS and MEDP stock pages for the full models.
Not investment advice.